Singapore O&G Q1 profit grows 24% to S$2.5m
SINGAPORE O&G's first-quarter net profit rose 23.7 per cent to S$2.5 million, or 0.52 Singapore cent per share, as both its core businesses and its new paediatrics segment contributed higher sales, the women's and children's clinic operator announced on Monday.
Revenue for the three months ended March 31 grew 17.3 per cent to S$8.2 million. Of the S$1.2 million increase in sales, S$0.5 million came from the obstetrics and gynaecology segment, S$0.4 million from the cancer-related segment and S$0.1 million from the dermatology segment. The group's new paediatric business, which comprises two clinics opened in 2017, accounted for S$0.2 million of the revenue increase.
Employee remuneration costs grew 12.2 per cent to S$3.2 million during the quarter, largely attributable to the addition of two specialist medical practitioners. As a group, specialist medical practitioners took 75 per cent of total remuneration expenses for the first quarter, compared to a 69.8 per cent share a year ago.
Looking ahead, Singapore O&G's directors expect the company to remain profitable in the next reporting period and for the next 12 months.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Seatrium unit to fully redeem S$500 million worth of floating-rate bonds early
Yeo Guat Kwang, John Chen retiring from corporate boards
US: Wall St opens higher
Air China orders homegrown C919s in challenge to jet duopoly
HCA beats first-quarter profit estimates on higher patient admissions
F&B operator YKGI to exclusively operate Chicha San Chen in Macau for next eight years